Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Carpentier

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulationKelly Verhelst, Lynn Verstrepen, Beatrice Coornaert, et al.
Immunological Reviews|June 19, 2015
The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitinationLynn Elton, Isabelle Carpentier, Kelly Verhelst, et al.
Cancer Investigation|June 14, 2013
The use of transdermal buprenorphine to relieve radiotherapy-related pain in head and neck cancer patientsJohan Menten, Isabelle Carpentier, Harlinde Deschutter, et al.
Biochemical and Biophysical Research Communications|August 12, 2015
XEDAR activates the non-canonical NF-κB pathwayKelly Verhelst, Sandra Gardam, Alice Borghi, et al.
The FEBS Journal|November 18, 2015
MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signalingLynn Elton, Isabelle Carpentier, Jens Staal, et al.
Biochemical Pharmacology|July 6, 2010
Expression, biological activities and mechanisms of action of A20 (TNFAIP3)Lynn Verstrepen, Kelly Verhelst, Geert van Loo, et al.
Canadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|January 13, 2016
[Intelligent videosurveillance and falls detection: Perceptions of professionals and managers]Nolwenn Lapierre, Isabelle Carpentier, Alain St-Arnaud, et al.
Journal of Cellular and Molecular Medicine|December 18, 2007
Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaBLynn Verstrepen, Minou Adib-Conquy, Marja Kreike, et al.
The EMBO Journal|October 4, 2012
A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7Kelly Verhelst, Isabelle Carpentier, Marja Kreike, et al.
Cancer Medicine|May 1, 2021
Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanomaMarie-Alix Mangin, Amélie Boespflug, Delphine Maucort Boulch, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulationKelly Verhelst, Lynn Verstrepen, Beatrice Coornaert, et al.
Immunological Reviews|June 19, 2015
The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitinationLynn Elton, Isabelle Carpentier, Kelly Verhelst, et al.
Cancer Investigation|June 14, 2013
The use of transdermal buprenorphine to relieve radiotherapy-related pain in head and neck cancer patientsJohan Menten, Isabelle Carpentier, Harlinde Deschutter, et al.
Biochemical and Biophysical Research Communications|August 12, 2015
XEDAR activates the non-canonical NF-κB pathwayKelly Verhelst, Sandra Gardam, Alice Borghi, et al.
The FEBS Journal|November 18, 2015
MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signalingLynn Elton, Isabelle Carpentier, Jens Staal, et al.
Biochemical Pharmacology|July 6, 2010
Expression, biological activities and mechanisms of action of A20 (TNFAIP3)Lynn Verstrepen, Kelly Verhelst, Geert van Loo, et al.
Canadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|January 13, 2016
[Intelligent videosurveillance and falls detection: Perceptions of professionals and managers]Nolwenn Lapierre, Isabelle Carpentier, Alain St-Arnaud, et al.
Journal of Cellular and Molecular Medicine|December 18, 2007
Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaBLynn Verstrepen, Minou Adib-Conquy, Marja Kreike, et al.
The EMBO Journal|October 4, 2012
A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7Kelly Verhelst, Isabelle Carpentier, Marja Kreike, et al.
Cancer Medicine|May 1, 2021
Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanomaMarie-Alix Mangin, Amélie Boespflug, Delphine Maucort Boulch, et al.
Pageof 3